扩张型心肌病
细胞生物学
心肌病
化学
平衡
GPX4
线粒体
氧化应激
脂质代谢
脂质过氧化
心磷脂
活性氧
β氧化
生物
体内
癌症研究
KEAP1型
内科学
生物化学
炎症
心室重构
欧米茄3脂肪酸
基因剔除小鼠
体外
脂毒性
内分泌学
氧化磷酸化
心功能曲线
超氧化物歧化酶
信号转导
细胞质
作者
Nannan Tang,Ruxue Mu,He Wang,Jiaying Wu,Jie Zhang (64655),Di Huang,Yannan Han,Wenjian Li,Yuqing Chen,Xiang Li,Yilin Sun,Zifeng Zhang,Jinlu Zuo,Ying Hu (14950),Yanan Yin,Yang Qu (681035),Jinping Liu,Lei Jiao,Xue Liu,Haihai Liang
标识
DOI:10.1038/s41418-026-01679-9
摘要
Dilated cardiomyopathy (DCM) was the most prevalent cardiomyopathy worldwide. Although ferroptosis has been implicated in cardiac pathogenesis, its regulatory mechanism in DCM remained poorly defined. In this study, we found that GIPC1 (GAIP/RGS19-interacting protein), a scaffolding protein, was significantly downregulated in cardiac tissues from DCM patients and doxorubicin (DOX)-induced DCM models. Integrated proteomic and lipidomic analysis revealed that cardiac-specific knockout of GIPC1 disrupted mitochondrial fatty acid metabolism, increased the abundance of polyunsaturated fatty acid-containing phospholipids (PUFA-PLs), and ultimately promoted ferroptosis in cardiomyocytes. Both in vitro and in vivo experiments demonstrated that GIPC1 deficiency exacerbated ferroptosis and cardiac dysfunction in DOX-induced cardiomyopathy, whereas GIPC1 overexpression conferred protection against ferroptosis in DOX-induced cardiomyopathy. Mechanistically, co-immunoprecipitation mass spectrometry (Co-IP/MS) and molecular docking demonstrated that GIPC1 interacted with mitochondrial 2,4-dienoyl-CoA reductase (DECR1) via its PDZ domain. Surface plasmon resonance (SPR) analysis further confirmed a high-affinity direct binding between GIPC1 and DECR1 (KD = 16.3 nM). Co-IP and immunofluorescence (IF) demonstrated that GIPC1 facilitated actin-dependent transport of DECR1 into mitochondria, thereby maintaining redox homeostasis and suppressing ferroptosis. Consistently, DECR1 overexpression rescued GIPC1 ablation-induced ferroptosis by balancing redox homeostasis. Together, these results demonstrated that GIPC1 reduced cardiomyocyte susceptibility to ferroptosis by promoting mitochondrial translocation of DECR1 and remodeling lipid homeostasis, highlighting GIPC1/DECR1 axis as a potential therapeutic strategy for DCM. A schematic model illustrating the pathogenic cascade triggered by GIPC1 deficiency during DCM. In DCM, the expression level of GIPC1 was downregulated, thereby inhibiting actin-dependent transport of DECR1 into mitochondria, which remodeled lipid homeostasis and ultimately induced cardiomyocytes ferroptosis. Created with Figdraw.com.
科研通智能强力驱动
Strongly Powered by AbleSci AI